|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Enoxaparin#Adult Indications and Dosage]] |
| {{Enoxaparin}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Indications and Usage==
| |
| ===Prophylaxis of Deep Vein Thrombosis===
| |
| | |
| Lovenox® is indicated for the prophylaxis of [[deep vein thrombosis ]]([[DVT]]), which may lead to [[pulmonary embolism]] ([[PE]]):
| |
| | |
| in patients undergoing abdominal surgery who are at risk for thromboembolic complications [see Clinical Studies (14.1)].
| |
| in patients undergoing hip replacement surgery, during and following hospitalization.
| |
| in patients undergoing knee replacement surgery.
| |
| in medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness.
| |
| | |
| ===Treatment of Acute Deep Vein Thrombosis===
| |
| | |
| Lovenox is indicated for:
| |
| | |
| the inpatient treatment of acute [[deep vein thrombosis ]]with or without [[pulmonary embolism]], when administered in conjunction with [[warfarin]] sodium.
| |
| the outpatient treatment of acute [[deep vein thrombosis ]]without [[pulmonary embolism]] when administered in conjunction with [[warfarin]] sodium.
| |
| | |
| ===Prophylaxis of Ischemic Complications of [[Unstable Angina]] and Non-Q-Wave [[Myocardial Infarction]]===
| |
| | |
| Lovenox is indicated for the prophylaxis of ischemic complications of [[Unstable Angina]] and non-Q-wave [[Myocardial Infarction]], when concurrently administered with aspirin.
| |
| | |
| ===Treatment of Acute ST-Segment Elevation [[Myocardial Infarction]]===
| |
| | |
| Lovenox, when administered concurrently with aspirin, has been shown to reduce the rate of the combined endpoint of recurrent [[Myocardial Infarction]] or death in patients with acute ST-segment elevation [[Myocardial Infarction]] (STEMI) receiving thrombolysis and being managed medically or with [[PE]]rcutaneous coronary intervention (PCI).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5017a927-2a24-4f27-89f9-27c805bf7d59 | publisher = | date = | accessdate = 6 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |